ADAC Laboratories has forged an exclusive vendor agreement with PET radiopharmaceutical manufacturer Eastern Isotopes. The partnership gives ADAC access to 5.5 millicurie doses of FDG, which it will buy at a discount from Eastern Isotopes, and allows it
ADAC Laboratories has forged an exclusive vendor agreement with PET radiopharmaceutical manufacturer Eastern Isotopes. The partnership gives ADAC access to 5.5 millicurie doses of FDG, which it will buy at a discount from Eastern Isotopes, and allows it to supply its molecular coincidence detection/attenuation correction (MCD/AC) and CPET customers. ADACs FDG imaging products do not require 10 millicurie doses of the radioisotope, as competitive products do, according to the Milpitas, CA, company.
Based in Sterling, VA, Eastern Isotopes was established in 1995 as a distributor of SPECT pharmaceuticals. Last year, the firm began to produce high-energy tracers, particularly FDG, for therapy, oncology, cardiology, and neurology.
With the deal, ADAC continues its push into the PET market, capitalizing on the momentum created by its September purchase of partner UGM Medical, a developer and manufacturer of PET devices (SCAN 9/29/99). The two firms codeveloped ADACs MCD high-energy imaging option for gamma cameras (SCAN 12/14/94).
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.